Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart review
- PMID: 35325848
- PMCID: PMC8934717
- DOI: 10.1016/j.biopha.2022.112843
Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart review
Abstract
The coronavirus disease 2019 (COVID-19) has overwhelming healthcare systems globally. To date, a myriad of therapeutic regimens has been employed in an attempt to curb the ramifications of a severe COVID-19 infection. Amidst the ongoing pandemic, the advent and efficacious uptake of COVID-19 vaccination has significantly reduced disease-related hospitalizations and mortality. Nevertheless, many side-effects are being reported after COVID-19 vaccinations and myocarditis is the most commonly reported sequelae post vaccination. Majority of these diseases are associated with COVID-19 mRNA vaccines. Various studies have established a temporal relationship between these complications, yet the causality and the underlying pathogenesis remain hypothetical. In this review, we aim to critically appraise the available literature regarding the cardiovascular side effects of the various mRNA vaccines and the associated pathophysiology.
Keywords: COVID-19 mRNA vaccine; COVID-19 myocarditis; COVID-19 perimyocarditis; Coronavirus 2019 (COVID-19); SARS-CoV-2; Takotsubo syndrome.
Copyright © 2022 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Figures
References
-
- Ritchie H., Mathieu E., Rodés-Guirao L., 2021. et al. Coronavirus (COVID-19) vaccinations - statistics and research. Our World in Data. 〈https://ourworldindata.org/covid-vaccinations〉. Published March 5, 2020. Accessed 4 December 2021.
-
- Lopez Bernal J., Andrews N., Gower C., Gallagher E., Simmons R., Thelwall S., Stowe J., Tessier E., Groves N., Dabrera G., Myers R., Campbell C.N.J., Amirthalingam G., Edmunds M., Zambon M., Brown K.E., Hopkins S., Chand M., Ramsay M. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant. N. Engl. J. Med. 2021;385(7):585–594. doi: 10.1056/NEJMoa2108891. Epub 2021 Jul 21. PMID: 34289274; PMCID: PMC8314739. - PMC - PubMed
-
- Eckart R.E., Love S.S., Atwood J.E., Arness M.K., Cassimatis D.C., Campbell C.L., Boyd S.Y., Murphy J.G., Swerdlow D.L., Collins L.C., Riddle J.R., Tornberg D.N., Grabenstein J.D., Engler R.J. Department of defense smallpox vaccination clinical evaluation team. incidence and follow-up of inflammatory cardiac complications after smallpox vaccination. J. Am. Coll. Cardiol. 2004;44(1):201–205. doi: 10.1016/j.jacc.2004.05.004. PMID: 15234435. - PubMed
-
- Myocarditis and pericarditis after mrna COVID-19 vaccination. Centers for Disease Control and Prevention. 〈https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.h.... Accessed 4 December 2021.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
